Changing Trends in Advanced Epithelial Ovarian Cancer - A Review

Authors

  • D. K. Vijay kumar Professor and Head Amrita Institute of Medical Sciences and Research Centre Surgical and Gynaecologic Oncology Amrita Lane, AIMS, Ponekkara Kochi, Kerala.
  • Anupama Rajanbabu Department of Gynecologic Oncology, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwavidyapeetham, Cochin-682041, Kerala, India

DOI:

https://doi.org/10.37591/rrjooh.v3i2.1340

Abstract

Despite the advances in surgery and chemotherapy, the outcome of patients affected with advanced epithelial ovarian cancer continues to be poor. Now researchers are looking at ovarian cancer through newer perspectives so as to find better treatment modalities that can improve overall survival (OS).  In this chapter, we have briefly reviewed the newer areas of research in epithelial ovarian cancer. We look at how better understanding of the molecular biology, changes in mode of chemotherapy administration and newer targeted agents have improved the outlook for the future.

 

Keywords: Epithelial ovarian cancer, Cancer stem cell, Optimal debulking, Chemotherapy in ovarian cancer

 

Published

2019-04-10

Issue

Section

Review Article